US › Healthcare

DocGo Inc (DCGO)

US · Healthcare · Medical Care Facilities

$0.65+0.62%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$75.6M

Revenue YoY

-21.3%

Net profit

$-14.8M

Profit YoY

-57.0%

EPS

$-0.33

EPS estimate

$-0.06

Net margin

-19.5%

EPS came in at -0.33 against a street estimate of -0.06 — a miss of 450.0%.

Key statistics

Market cap

$64.3M

Forward P/E

60.2

P/B

0.49

Book value

$1.34

EPS (TTM)

$-1.90

52-week high

$1.78

52-week low

$0.45

50-day MA

$0.59

200-day MA

$0.77

Beta

1.02

Analyst view

Analysts rate DocGo Inc a buy (4 buy, 3 hold, 0 sell out of 7) with an average price target of $1.88.

Shareholding

Insiders

3.07%

Institutions

45.45%

Largest institutional holders

Fund	Stake
BlackRock Inc	6.44%
Vanguard Capital Management, LLC	3.73%
P.a.w. Capital Corp	3.55%
Knott David M Jr	2.70%
Peapod Lane Capital LLC	2.53%
Citadel Advisors Llc	2.53%
Geode Capital Management, LLC	2.44%
S Squared Technology, LLC	2.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for DocGo Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.